![Immunohistochemistry-Paraffin: SLC26A9 Antibody [NBP2-30425] - Staining in human stomach and pancreas tissues using anti-SLC26A9 antibody. Corresponding SLC26A9 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/SLC26A9-Antibody-Immunohistochemistry-Paraffin-NBP2-30425-img0006.jpg "Immunohistochemistry-Paraffin: SLC26A9 Antibody [NBP2-30425] - Staining in human stomach and pancreas tissues using anti-SLC26A9 antibody. Corresponding SLC26A9 RNA-seq data are presented for the same tissues.")
| Reactivity | Hu, Ha, Mu, RtSpecies Glossary |
| Applications | ICC/IF, IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Immunogen | This antibody was developed against a recombinant protein corresponding to amino acids: MSQPRPRYVVDRAAYSLTLFDDEFEKKDRTYPVGEKLRNAFRC |
| Predicted Species | Mouse (91%), Rat (91%). Backed by our 100% Guarantee. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | SLC26A9 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
||
| Application Notes | For IHC-Paraffin, HIER pH 6 retrieval is recommended. ICC/IF Fixation Permeabilization: Use PFA/Triton X-100. |
||
| Control Peptide |
|
||
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.2) and 40% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Purity | Immunogen affinity purified |
Secondary Antibodies |
Isotype Controls |
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunocytochemistry/Immunofluorescence: SLC26A9 Antibody [NBP2-30425] - Staining of human cell line A549 shows localization to cell junctions. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/SLC26A9-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-30425-img0003.jpg "Immunocytochemistry/Immunofluorescence: SLC26A9 Antibody [NBP2-30425] - Staining of human cell line A549 shows localization to cell junctions. Antibody staining is shown in green.")
![Immunohistochemistry-Paraffin: SLC26A9 Antibody [NBP2-30425] - Staining of human pancreas shows low expression as expected.](http://images.novusbio.com/fullsize/SLC26A9-Antibody-Immunohistochemistry-Paraffin-NBP2-30425-img0004.jpg "Immunohistochemistry-Paraffin: SLC26A9 Antibody [NBP2-30425] - Staining of human pancreas shows low expression as expected.")
![Immunohistochemistry-Paraffin: SLC26A9 Antibody [NBP2-30425] - Staining of human stomach shows high expression.](http://images.novusbio.com/fullsize/SLC26A9-Antibody-Immunohistochemistry-Paraffin-NBP2-30425-img0005.jpg "Immunohistochemistry-Paraffin: SLC26A9 Antibody [NBP2-30425] - Staining of human stomach shows high expression.")
![Immunohistochemistry CFTR Antibody (24-1) [Unconjugated] - C-terminus](https://images.novusbio.com/images2/CFTR_MAB25031_Immunohistochemistry_6973.jpg)
![Immunohistochemistry CFTR Antibody (24-1) [Unconjugated] - C-terminus](https://images.novusbio.com/images2/CFTR_MAB25031_Immunohistochemistry_9671.jpg)
![Immunoprecipitation CFTR Antibody (24-1) [Unconjugated] - C-terminus](https://images.novusbio.com/images/mab25031_human-cftr-c-terminus-mab-clone-24-1-41202412513815.jpg)
![SDS-PAGE FGF-10 [Unconjugated]](https://images.novusbio.com/images2/FGF-10_345-FG_557.jpg)
![Bioactivity FGF-10 [Unconjugated]](https://images.novusbio.com/images2/FGF-10_345-FG_559.jpg)
![Bioactivity FGF-10 [Unconjugated]](https://images.novusbio.com/images/345-fg_recombinant-human-fgf-10-protein-bioactivity-2520239220..jpg)
![N/A IL-13 [Biotin]](https://images.novusbio.com/images2/DATA_IL13_DY413_ELISA_2010.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")